Skip to main content

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).

A live webcast may be accessed through the investor relations section of the Natera website at investor.natera.com. A replay of the event will be available shortly following the conference.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Contacts

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.95
+0.00 (0.00%)
AAPL  258.45
+0.00 (0.00%)
AMD  230.23
+0.00 (0.00%)
BAC  51.10
+0.00 (0.00%)
GOOG  252.53
+0.00 (0.00%)
META  733.41
+0.00 (0.00%)
MSFT  520.54
+0.00 (0.00%)
NVDA  180.28
+0.00 (0.00%)
ORCL  272.66
+0.00 (0.00%)
TSLA  438.97
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.